Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quipt Home Medical (QIPT) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Quipt Home Medical (QIPT) over the last 6 years, with Q4 2025 value amounting to -$9.4 million.

  • Quipt Home Medical's Cash from Financing Activities fell 7093.44% to -$9.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$11.7 million, marking a year-over-year increase of 5034.24%. This contributed to the annual value of -$7.8 million for FY2025, which is 7032.93% up from last year.
  • As of Q4 2025, Quipt Home Medical's Cash from Financing Activities stood at -$9.4 million, which was down 7093.44% from $15.2 million recorded in Q3 2025.
  • Quipt Home Medical's 5-year Cash from Financing Activities high stood at $15.2 million for Q3 2025, and its period low was -$11.8 million during Q2 2025.
  • Over the past 5 years, Quipt Home Medical's median Cash from Financing Activities value was -$5.3 million (recorded in 2024), while the average stood at -$3.0 million.
  • In the last 5 years, Quipt Home Medical's Cash from Financing Activities plummeted by 128200.0% in 2023 and then surged by 40284.18% in 2025.
  • Over the past 5 years, Quipt Home Medical's Cash from Financing Activities (Quarter) stood at -$4.3 million in 2021, then tumbled by 94.12% to -$8.4 million in 2022, then grew by 2.74% to -$8.2 million in 2023, then surged by 32.31% to -$5.5 million in 2024, then plummeted by 70.93% to -$9.4 million in 2025.
  • Its Cash from Financing Activities stands at -$9.4 million for Q4 2025, versus $15.2 million for Q3 2025 and -$11.8 million for Q2 2025.